Title
Protecting Scientific Integrity and Public Policy Pronouncements on COVID-19
Authors
Abstract
The SARS-CoV-2 virus and the associated COVID-19 disease is a pandemic that has rocked the world in terms of public health and medical issues, business, economics and finance. Interesting and topical discussions regarding risk management of COVID-19 have been reported in leading business, economics, finance, and medical journals, as well as information and misinformation, intended or not, in the mass media. In this context, protecting the integrity of public policy pronouncements relating to the conduct and outcomes of scientific clinical trials. In terms of protecting the scientific integrity of clinical trials of COVID-19 patients, it is intentional to determine whether imperfectly collected data on clinical trials are more useful than having no data at all.
Keywords
COVID-19; SARS-CoV-2; scientific integrity; public policy pronouncements; medical research; business, economics and finance
Classification-JEL
D81, G32, H12, L82
Pages
70-84
https://doi.org/10.47654/v24y2020i1p70-84
WHO COVID-19 Global literature on coronavirus disease (ID: covidwho-828530)
https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/covidwho-828530